Myungin Pharma Declares Interim Cash Dividend of KRW 500 per Share, Dividend Yield 1.2%
Myungin Pharma has resolved to pay an interim cash dividend of KRW 500 per common share. The total dividend amounts to KRW 7.3 billion with a dividend yield of 1.2% which is relatively low.
The record date is August 31 2026 and the payment date is September 8 2026. The board resolution was made on July 28 2026.
All three outside directors attended the board meeting and approved the agenda. No separate general shareholders' meeting will be held.
[AI Summary]The interim dividend reflects the company's ongoing shareholder return policy but the low yield of 1.2% offers limited income appeal. The impact on capital structure is neutral and the decision poses no significant dilution or growth implications for shareholders.